Menin inhibitors for patients with relapsed/refractory acute myeloid leukemia (AML): a systematic review and meta-analysis
In this Review article, which was recently published in Leukemia & Lymphoma, the authors evaluate the efficacy and…
New therapy targets Hippo pathway to fight treatment-resistant acute myeloid leukemia
Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy remained effective in treatment-resistant acute myeloid…
Study explains how leukemia creates inflammatory lung environments
Acute myeloid leukemia (AML) does more than infiltrate the lungs: it also transforms lung tissue to create an…
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
Moleculin Biotech, Inc. Moleculin Biotech, Inc. INTERIM EFFICACY – N=45 INTENT TO TREAT (ITT) Both Annamycin dose arms…
Dr. Soheil Meshinchi, a leading expert in acute myeloid leukemia, named Dylan Burke Endowed Chair in Immunotherapy
As a child, Dylan Burke was an athlete and gymnast who shunned sugar and worked out every day, and a budding mad…
RNA Splicing Errors Drive Leukemia
By: Staff Writer | January 02, 2026 | 7 min. read | Share Summary A new study from Sylvester Comprehensive…
Timing of genetic mutation dictates childhood leukemia aggressiveness
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with…
Research shows the potential of structural nanomedicine in cancer treatment
In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of a common…